Bradford Zakes recently helped combine the Seattle-area biotech company he led, Cerevast Medical, with two startups to create a new company. Now he’s poised to take Longevity Biomedical public as… Read More
Cerevast Therapeutics, a 5-year-old Redmond company that’s developing a novel approach for treating stroke patients with ultrasound, has raised $10 million in fresh funding, according to a filing with the SEC.… Read More